DNActive is able to determine a person’s predisposition to major diseases and pathologies such as diabetes, osteoporosis, and celiac disease through a personalised genetic tests. The startup can determine an individual’s risk, and use that as a basis to provide personalised guidelines such as disease prevention plans, diets, exercises, or supplements, to prevent the disease from appearing or mitigate its symptoms. It works with clinics and laboratories, pharmacies, and directly with patients through its website.